Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous s stock reports and market updates.
AmerisourceBergen Corp. (NYSE: ABC) shares declined 0.98 percent to close at $65.00 a share Thursday. The stock traded between $64.74 and $66.18 on volume of 2.10 million shares traded. Analysts at FBR Capital have recently upgraded the company’s rating to "outperform" from "market perform". Shares of AmerisourceBergen have fallen approximately 8.0 percent year-to-date.
Find out more about AmerisourceBergen including full access to the free equity report at:
Harvard Apparatus Regenerative Tech Inc. (NASDAQ: HART) shares gained 7.67 percent to close at $9.55 a share Thursday. The stock traded between $8.59 and $9.89 on volume of 724,661 shares traded. Analysts at Summer Street have recently initiated coverage on the company with a "buy' rating and a price target of $24.00. Shares of Harvard Apparatus have gained approximately 100.0 percent year-to-date.
Find out more about Harvard Apparatus including full access to the free equity report at:
Premier Inc. (NASDAQ: PINC) shares declined 1.75 percent to close at $32.62 a share Thursday. The stock traded between $32.54 and $35.00 on volume of 148,950 shares traded. Analysts at ISI Group have recently upgraded the company’s rating to "buy" from "neutral". Shares of Premier have fallen approximately 11.0 percent year-to-date.
Find out more about Premier including full access to the free equity report at:
Wright Medical Group Inc. (NASDAQ: WMGI) shares declined 0.34 percent to close at $29.09 a share Thursday. The stock traded between $28.57 and $30.92 on volume of 832,641 shares traded. Analysts at Robert W. Baird have recently upgraded the company’s rating to "outperform" from "neutral". Shares of Wright Medical Group have fallen approximately 5.0 percent year-to-date.
Find out more about Wright Medical Group including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing